# VISUM PHARMA, INC. — Form D

VISUM PHARMA, INC. of STAMFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-02. The offering totals $2.5M, of which $1.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-11-02
- Form: D
- Accession: 0001839991-21-000003
- Industry: Pharmaceuticals
- Exemptions: 06b, 4a5
- Total offering: $2.5M
- Amount sold: $1.2M
- Remaining: $1.3M
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2021-10-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-419440

## Issuer

- Name: VISUM PHARMA, INC.
- CIK: 0001883978
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 48 GURLEY ROAD, STAMFORD, CT, 06902
- Phone: 9146735570

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Mark Smith | Executive Officer | Palo Alto, CA |
| Bernard J Peperstraete | Director | Stamford, CT |
| Peter J Vanderklish | Director | Stamford, CT |
| John J Costantino | Director | Stamford, CT |
| Alex J Cuomo | Executive Officer | Stamford, CT |
| William J Gedale | Director | Stamford, CT |
| William J Gedale | Executive Officer | Stamford, CT |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-09-13](https://search.stillhousedata.com/formd/0001883978-23-000001) | D | $300K | $50K |

## More

- [CIK 1883978 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1883978&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001839991-21-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.